VFT Domain Protein FRET Screening for GPCR Modulators
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Current techniques are inadequate for efficiently screening compounds that modulate the activation state of dimeric class C GPCRs, particularly due to low affinity of mGlu receptors and complexity of effector pathways, leading to difficulties in detecting agonist effects and background noise from intracellular compartments.
Innovation Solution
A method involving marking VFT domain proteins with FRET partners and measuring FRET signals in specific time windows to identify compounds that modulate the activation state of dimeric class C GPCRs, allowing for the detection of differences in FRET signals in the presence and absence of test compounds.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Measurement precision
If conventional screening techniques are used to detect compounds modulating class C GPCRs, then the screening can be performed with standard methods, but the detection precision is insufficient due to low affinity of mGlu receptors and background noise from intracellular compartments
Solution Approach 1:
The invention segments the measurement process by using time-resolved FRET signaling to separate the detection of modulator compounds from background noise. By measuring FRET signals at specific time points (e.g., 40-80 milliseconds after agonist addition), the method isolates the relevant signal from intracellular compartment noise, thereby improving detection precision without requiring overly complex screening systems
Solution Approach 2:
The invention introduces FRET partners as intermediary molecules that bind to the modulator compounds and transmit detection signals. The FRET partner system acts as a mediator between the modulator compound and the detection system, enabling precise detection of compound-receptor interactions while filtering out background noise from intracellular compartments
2Measurement precision
If FRET signals are measured in standard time windows, then the measurement process is simple, but the modulatory effects of compounds cannot be accurately distinguished due to signal overlap and background noise
Solution Approach 1:
The invention employs periodic action by measuring FRET signals at specific time intervals after agonist addition (e.g., 40-80 milliseconds). This time-resolved measurement approach allows the system to capture modulator compound effects at optimal time points when the signal is most distinct from background noise, improving accuracy without requiring continuous monitoring
Solution Approach 2:
The invention applies preliminary action by pre-determining the optimal time window for FRET signal measurement based on the known kinetics of the receptor system. By establishing these time parameters in advance, the method enables accurate distinction of modulatory effects during actual screening without requiring real-time optimization, thus reducing measurement time while maintaining precision
Applied Scientific Principles
This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.
Function Achieved in This Case
Enables the simple and effective screening of large libraries of compounds for their effects on membrane proteins with VFT domains, including class C GPCRs, facilitating the discovery of new drugs by accurately distinguishing modulatory effects.
Implementation Method 1
marking of the first and second proteins in the N-terminal part of their VFT domains by members of a pair of FRET partners; excitation of FRET partners and measurement of the FRET signal
Data Source
Figure 1~2
Figure 3~4
Figure 5~6
AI summary
The invention relates to a method for selecting compounds having a modulating effect on the activation state of a dimer of VFT domain proteins expressed in cellular membranes in a measuring medium, said dimer including a first protein and a second protein which are identical or different, wherein the method includes the following steps: (a) marking the first and second proteins in the N-terminal portion of the VFT domain by members of a FRET partner pair, the Förster radius (R0) of said pair ranging between 20 and 55 Å; (b) measuring the FRET signal in the absence and in the presence of the compound to be tested within a predetermined time window; (c) selecting the compound to be tested as a modulating compound if a difference in the FRET signal in the absence and in the presence of the compound to be tested is measured during step (b). The invention can be used in the research for new drugs and new taste modulators.